These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23793769)

  • 1. [Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease].
    Maroto Rey JP; Cillán Narvaez E
    Arch Esp Urol; 2013 Jun; 66(5):517-23. PubMed ID: 23793769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of renal cell carcinoma.
    Wagner JR; Linehan WM
    Semin Urol Oncol; 1996 Nov; 14(4):244-9. PubMed ID: 8946625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary and familial kidney cancer.
    Coleman JA; Russo P
    Curr Opin Urol; 2009 Sep; 19(5):478-85. PubMed ID: 19584731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cancer genetics: von Hippel Lindau and other syndromes.
    Fleming S
    Int J Dev Biol; 1999; 43(5):469-71. PubMed ID: 10535326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness].
    Zudaire Bergera JJ; Rincón Mayans A; Rioja Zuazu J; Barba Abad J; Romero Vargas L; Algarra Navarro R; Tienza Fernández A; Robles García JE; Rosell Costa D; Berián Polo JM; Pascual Piédrola JI
    Arch Esp Urol; 2013; 66(1):23-32. PubMed ID: 23406797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the hepatocyte growth factor/c-Met signaling pathway in renal cell carcinoma.
    Harshman LC; Choueiri TK
    Cancer J; 2013; 19(4):316-23. PubMed ID: 23867513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-clear cell advanced kidney cancer: is there a gold standard?
    Sánchez P; Calvo E; Durán I
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S9-14. PubMed ID: 21173605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
    Gnarra JR; Lerman MI; Zbar B; Linehan WM
    Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors.
    Kim CM; Vocke C; Torres-Cabala C; Yang Y; Schmidt L; Walther M; Linehan WM
    J Urol; 2006 May; 175(5):1908-14. PubMed ID: 16600797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Strategies for Hereditary Kidney Cancer.
    Sidana A; Srinivasan R
    Curr Oncol Rep; 2016 Aug; 18(8):50. PubMed ID: 27325049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational therapy for renal cell carcinoma based on its genetic targets.
    Messer J; Drabick J; Kaag M
    Adv Exp Med Biol; 2013; 779():291-308. PubMed ID: 23288645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal cell carcinoma: A review of the current therapeutic landscape.
    Courthod G; Tucci M; Di Maio M; Scagliotti GV
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):100-12. PubMed ID: 26052049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary renal cell carcinoma: current progress and future directions.
    Twardowski PW; Mack PC; Lara PN
    Clin Genitourin Cancer; 2014 Apr; 12(2):74-9. PubMed ID: 24629521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma: recent advances in genetics and imaging.
    Choudhary S; Sudarshan S; Choyke PL; Prasad SR
    Semin Ultrasound CT MR; 2009 Aug; 30(4):315-25. PubMed ID: 19711643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced nccRCC: what therapeutic options in 2022?
    Bigot C; Boudier P; Ladoire S; Barthélémy P
    Bull Cancer; 2022 May; 109(2S):2S39-2S46. PubMed ID: 35760469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic science and research in renal cell carcinoma: from workbench to bedside.
    Heidenreich A; Schrader AJ; Varga Z
    Curr Opin Urol; 2003 Nov; 13(6):457-62. PubMed ID: 14560138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cancer: molecular mechanisms and newer therapeutic options.
    Karumanchi SA; Merchan J; Sukhatme VP
    Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):37-42. PubMed ID: 11753085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.